Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Consolidated Net Income: 2021-2022

Historic Consolidated Net Income for Milestone Pharmaceuticals (MIST) over the last 1 years, with Sep 2022 value amounting to -$14.6 million.

  • Milestone Pharmaceuticals' Consolidated Net Income fell 2.33% to -$14.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$58.2 million, marking a year-over-year change of. This contributed to the annual value of -$42.9 million for FY2021, which is 14.24% up from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Consolidated Net Income of -$14.6 million as of Q3 2022, which was up 13.79% from -$16.9 million recorded in Q4 2021.
  • Milestone Pharmaceuticals' 5-year Consolidated Net Income high stood at -$12.5 million for Q2 2021, and its period low was -$16.9 million during Q4 2021.
  • In the last 2 years, Milestone Pharmaceuticals' Consolidated Net Income had a median value of -$14.4 million in 2021 and averaged -$14.5 million.
  • Data for Milestone Pharmaceuticals' Consolidated Net Income shows a maximum YoY fell of 2.33% (in 2022) over the last 5 years.
  • Milestone Pharmaceuticals' Consolidated Net Income (Quarterly) stood at -$16.9 million in 2021, then fell by 2.33% to -$14.6 million in 2022.
  • Its last three reported values are -$14.6 million in Q3 2022, -$16.9 million for Q4 2021, and -$14.2 million during Q3 2021.